Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.LinkMed, a private equity company in the life science sector, has said that it is acquiring 100% of the shares in Sweden-based biotechnology company Olerup SSP. The value of the acquisition is SEK216 million.
Subscribe to our email newsletter
LinkMed said that the acquisition will further strengthen its position in the transplantation sector and is strategically important in that it complements its portfolio company AbSorber and its XM-One product.
Olerup SSP’s products are primarily used prior to bone marrow transplantations, while Absorber’s product XM-One is mainly used prior to organ transplantations, with kidney transplantations being the most common. Both companies offer tests that are required before a transplantation operation in order to match the donor with the recipient.
The acquisition will be completed during July 2008. Subsequent to the acquisition, Olerup SPP will be a wholly owned subsidiary of LinkMed.